Skip to content
PubMed This is a summary of 74 peer-reviewed journal articles Updated
Pediatric Neurology

CNTNAP2-Related Developmental and Epileptic Encephalopathy: A Patient Guide

At a Glance

CNTNAP2-related DEE is a rare inherited condition caused by changes in both copies of the CNTNAP2 gene. It can lead to seizures, developmental and language delays, and autism-related features. Care focuses on seizure control, communication, and physical support.

Please note: This guide is intended for informational purposes and does not replace the individualized care of your child’s neurologist, genetic counselor, or emergency services.

CNTNAP2-related developmental and epileptic encephalopathy (DEE) is a rare and complex genetic condition that can significantly affect how the brain develops and communicates. It occurs when a child inherits a pathogenic variant (mutation) in both copies of the CNTNAP2 gene—one from each parent—resulting in a deficiency of a vital protein called CASPR2 [1]. Biological models suggest this protein acts as a master organizer in the nervous system, helping to position the electrical “brakes” on nerve fibers and ensuring that signals across the brain are clear and controlled. When CASPR2 is missing or dysfunctional, the brain can become hyper-excitable, leading to the seizures and developmental challenges that define this disorder [2][3].

The condition is classified as a Developmental and Epileptic Encephalopathy (DEE) because it impacts the brain in two interconnected ways. First, the genetic mutation itself alters the brain’s “wiring” from the earliest stages of development, leading to global developmental delays and profound language impairment. Second, the onset of epilepsy—often beginning in early childhood—can further disrupt the brain’s ability to learn and process information [4][5]. Because of this dual impact, children with this condition often experience features of autism spectrum disorder and may lose previously acquired communication skills, making early and consistent intervention a cornerstone of their care [6].

Living with CNTNAP2-related DEE requires a dedicated, multidisciplinary care team focused on the “whole child” rather than just the epilepsy. Management typically involves a combination of anti-seizure medications to stabilize brain activity and intensive therapies to support functional growth [7]. For many families, this includes using Augmentative and Alternative Communication (AAC) tools to bridge the gap created by severe speech delays, as well as physical and occupational therapies to manage challenges with muscle tone and coordination [8][9].

While the medical landscape of a rare genetic diagnosis is demanding, the focus of care is always on improving your child’s quality of life and safety. This involves vigilant monitoring for seizure changes, managing common health hurdles like sleep or digestive issues, and ensuring that you, as a caregiver, have the support and respite you need [10][11]. Although the journey is lifelong, understanding the biological “why” behind your child’s symptoms empowers you to advocate for the specialized, compassionate care they deserve.

Glossary of Key Terms

  • Biallelic / In Trans: Having two genetic variants, one inherited from each parent.
  • Cortical Dysplasia: An area where the outer layer of the brain (cortex) did not form perfectly.
  • Pharmacoresistant: Epilepsy that does not fully respond to standard anti-seizure medications.
  • Status Epilepticus: A prolonged seizure or series of seizures without recovery, requiring emergency intervention.
  • SUDEP: Sudden Unexpected Death in Epilepsy.
  • AAC: Augmentative and Alternative Communication (tools used to support speech, like picture boards or devices).

Common questions in this guide

What is CNTNAP2-related developmental and epileptic encephalopathy?
It is a rare inherited condition caused by disease-causing changes in both copies of the CNTNAP2 gene, with one change inherited from each parent. These changes can reduce or disrupt the CASPR2 protein, which helps control electrical signaling in the brain, leading to seizures and developmental challenges.
How can the gene change and seizures affect my child's development differently?
The CNTNAP2 change can alter brain development from early in life, contributing to developmental delay and severe language difficulties. Seizures can add to these challenges by disrupting learning and the brain's ability to process information, so both factors may need to be considered.
What symptoms are common in CNTNAP2-related DEE?
Children may have seizures, global developmental delay, severe speech or language impairment, autism spectrum features, and loss of communication skills they previously had. Muscle tone or coordination difficulties and sleep or digestive problems may also occur.
What treatments and therapies can support a child with CNTNAP2-related DEE?
Care often combines anti-seizure medicines with developmental and supportive therapies. Augmentative and Alternative Communication tools can support communication, while physical and occupational therapy can help with movement, muscle tone, and coordination; the plan is individualized by a multidisciplinary team.
What is CASPR2, and why does it matter in this condition?
CASPR2 is a protein that helps organize nerve fibers and keep electrical signals in the brain controlled. When it is missing or does not work properly, the brain may become overly excitable, which can contribute to seizures and developmental difficulties.
How can we monitor seizures and developmental progress over time?
Work with your child's neurologist and therapy team to review seizure changes alongside communication, learning, movement, and daily function. Tracking both areas helps the team adjust support and identify changing needs, while caregivers should also discuss sleep, digestion, safety, and their own need for support.
Who may be part of my child's CNTNAP2-related DEE care team?
A multidisciplinary team may include a pediatric neurologist, genetic counselor, and professionals providing communication, physical, and occupational therapies. The team can coordinate seizure care, developmental support, communication, safety, and caregiver support.

Get notified when new evidence is published on CNTNAP2-related developmental and epileptic encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder.

    D'Onofrio G, Accogli A, Severino M, et al.

    Human genetics 2023; (142(7)):909-925 doi:10.1007/s00439-023-02552-2.

    PMID: 37183190
  2. 2

    CNTNAP2 in neurodevelopmental disorders: Genetics, excitation/inhibition mechanisms and preclinical evidence.

    Dhungel A, Bora R, Chamidah AN, Menge DM

    Molecular and cellular neurosciences 2026; (139()):104127 doi:10.1016/j.mcn.2026.104127.

    PMID: 42815598
  3. 3

    Loss of Cntnap2 Causes Axonal Excitability Deficits, Developmental Delay in Cortical Myelination, and Abnormal Stereotyped Motor Behavior.

    Scott R, Sánchez-Aguilera A, van Elst K, et al.

    Cerebral cortex (New York, N.Y. : 1991) 2019; (29(2)):586-597 doi:10.1093/cercor/bhx341.

    PMID: 29300891
  4. 4

    Deciphering the concepts behind "Epileptic encephalopathy" and "Developmental and epileptic encephalopathy".

    Scheffer IE, Liao J

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2020; (24()):11-14 doi:10.1016/j.ejpn.2019.12.023.

    PMID: 31926847
  5. 5

    Developmental and epileptic encephalopathies: what we do and do not know.

    Specchio N, Curatolo P

    Brain : a journal of neurology 2021; (144(1)):32-43 doi:10.1093/brain/awaa371.

    PMID: 33279965
  6. 6

    Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum.

    Smogavec M, Cleall A, Hoyer J, et al.

    Journal of medical genetics 2016; (53(12)):820-827 doi:10.1136/jmedgenet-2016-103880.

    PMID: 27439707
  7. 7

    Beyond seizures: the hidden burden of developmental epileptic encephalopathies.

    Dell'Isola GB, Sorrentino M, Massara S, et al.

    Frontiers in neurology 2026; (17()):1960314 doi:10.3389/fneur.2026.1960314.

    PMID: 42953089
  8. 8

    Augmentative and Alternative Communication and Speech Production for Individuals with ASD: A Systematic Review.

    White EN, Ayres KM, Snyder SK, et al.

    Journal of autism and developmental disorders 2021; (51(11)):4199-4212 doi:10.1007/s10803-021-04868-2.

    PMID: 33511525
  9. 9

    SYNGAP1-related developmental and epileptic encephalopathy: The impact on daily life.

    Lo Barco T, De Gaetano L, Santangelo E, et al.

    Epilepsy & behavior : E&B 2022; (127()):108500 doi:10.1016/j.yebeh.2021.108500.

    PMID: 34954508
  10. 10

    The Hidden Cost of Developmental and Epileptic Encephalopathy in Australia: Caregiver Quality of Life, Sleep, Depression, and Workforce Participation.

    Kim H, Jones A, Lyu J, Lee L

    Pediatric neurology 2026; (182()):21-27 doi:10.1016/j.pediatrneurol.2026.06.001.

    PMID: 42372416
  11. 11

    Real-world experience of diagnosis, disability, and daily management in parents of children with different genetic developmental and epileptic encephalopathies: a qualitative study.

    Garcia-Bravo C, Palacios-Ceña D, Aledo-Serrano Á, et al.

    Annals of medicine 2025; (57(1)):2446702 doi:10.1080/07853890.2024.2446702.

    PMID: 39731461

This guide to CNTNAP2-related DEE is for informational purposes only and does not constitute medical advice or replace individualized care from your child's neurologist, genetic counselor, or other specialists. Seek emergency services for a prolonged seizure or another urgent change.